Please assess the completion status of the following clinical trial:

Trial Title: Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient age between 9-18 years~* Diagnosed obesity (BMI more than median plus two of standard deviation for age and sex according to WHO reference 2007)~Exclusion Criteria:~* Secondary obesity~* Thalassemia disease~* Renal and hepatic dysfunction~* Drugs: anticonvulsant, estrogen, thiazides, metformin, cholestyramine, methotrexate, fibrates, nicotinic acid~* Previous vitamin supplementation 1 month before study

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- placebo (Type: PLACEBO_COMPARATOR): placebo tablet in the same appearance and taste with folic acid orally once a day for 8 weeks of the study
- folic acid (Type: EXPERIMENTAL): Folic acid tablet 5mg per day orally (5mg/tablet) once a day for 8 weeks of the study

Based on this trial design, predict the completion outcome and termination type (if applicable).